See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

  • NRx Pharmaceuticals, Inc. announced that it will release its second quarter 2025 financial results after the market closes on August 19, 2025.
  • A conference call is scheduled for August 20, 2025, at 8:00 AM ET to discuss the results.
  • The company stated it requires additional time to compile information for the Form 10-Q and cannot complete it without unreasonable effort.
  • NRx Pharmaceuticals is a biopharmaceutical company that develops therapeutics for central nervous system disorders, including suicidal depression and PTSD.
Insights by Ground AI
Does this summary seem wrong?

44 Articles

LoudounTimes.comLoudounTimes.com
+42 Reposted by 42 other sources
Center

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Conference Call 8:00am ET, Wednesday August 20, 2025

Read Full Article
stocktitan.netstocktitan.net

NRx Pharmaceuticals Reschedules Q2 Earnings Call, Cites Need for Additional Financial Data Review

Clinical-stage biotech NRx Pharmaceuticals moves Q2 2025 results release to August 19, with investor call on August 20. Company needs extra time for Form 10-Q preparation. Get details.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States on Wednesday, August 13, 2025.
Sources are mostly out of (0)

Similar News Topics

United States icon

United States

News
For You
SearchBlindspotLocal